Table 1 The number (%) of studies reported clinical diagnosis concerning bacterial pathogen
From: Antibiotic resistance in Pakistan: a systematic review of past decade
Pathogen | N studies | UTI N(%) | EF N (%) | WI N (%) | RTI N (%) | BSI N (%) | DTI N (%) | MI N(%) | NM N (%) |
|---|---|---|---|---|---|---|---|---|---|
Acinetobacter spp | 15 | – | – | 1(6.67%) | 2(13.3%) | – | – | 3(20%) | 9(60%) |
E. coli | 28 | 13(46.4%) | – | 3(10.71%) | – | 2(7.14%) | 2*(7.1%) | – | 8(28.5%) |
Enterococcus spp | 4 | 2(50%) | – | – | – | – | – | – | 2(50%) |
H. pylori | 3 | – | – | – | – | – | 3(100%) | – | – |
Haemophilus spp | 1 | – | – | – | 1(100%) | – | – | – | – |
Klebsiella spp | 13 | 3(23.1%) | – | 2(15.3%) | – | 1(7.69%) | – | 2(15.38%) | 5(38.4%) |
N. gonorrhea. | 2 | 1(50%) | – | – | – | – | – | – | 1(50%) |
Proteus spp | 2 | – | – | 1(50%) | – | 1(50%) | – | – | – |
Pseudomonas spp | 13 | 1(7.7%) | – | 2(15.3)% | 1(7.69%) | 1(7.69%) | – | 2(15.38%) | 6(46.1%) |
S. aureus | 20 | – | – | 5(25%) | – | 1(5%) | – | 4(20%) | 10(50%) |
Salmonella spp | 10 | – | 10(100%) | – | – | – | – | – | – |
Shigella spp | 4 | – | – | – | – | – | 2(50%) | 1(25%) | 1(25%) |
Streptococcus spp | 2 | – | – | – | 2(100%) | – | – | – | – |